Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
age-related macular degeneration
Pharma
EyePoint's Duravyu bounces back with promising DME data
EyePoint revitalized its star asset Duravyu with strong diabetic macular edema data, opening a path forward for other potential retinal indications.
Fraiser Kansteiner
Oct 28, 2024 1:11pm
Astellas pulls application for Izervay after talks with CHMP
Oct 28, 2024 11:07am
Clearside's CLS-AX excels in phase 2b trial, set for phase 3
Oct 9, 2024 11:47am
Astellas cruises into first DTC campaign for GA med Izervay
Sep 30, 2024 4:00pm
FDA gives thumbs-up to Roche's Vabysmo in a prefilled syringe
Jul 8, 2024 10:35am
Genentech animated short spotlights docs' trust in Vabysmo
May 13, 2024 4:05pm
